Publication date: Available online 26 October 2026 Source: Journal of Thrombosis and Haemostasis Author(s): Claudia Kelsch, Juliana M.L. Biondo, Markus Niggli, Letizia Polito, Guillermo Tobaruela
Emicizumab Prophylaxis in People with Haemophilia A: Summary of Over 13 Years of Safety Data on Thromboembolic Events and Thrombotic Microangiopathy. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S1538783626006793?dgcid=rss_sd_all
Emicizumab Prophylaxis in People with Haemophilia A: Summary of Over 13 Years of Safety Data on Thromboembolic Events and Thrombotic Microangiopathy. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S1538783626006793?dgcid=rss_sd_all
“Emicizumab Prophylaxis in People with Haemophilia A: Summary of Over 13 Years of Safety Data on Thromboembolic Events and Thrombotic Microangiopathy.” Journal of Thrombosis and Haemostasis.
@article{article56482,
title = {Emicizumab Prophylaxis in People with Haemophilia A: Summary of Over 13 Years of Safety Data on Thromboembolic Events and Thrombotic Microangiopathy},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S1538783626006793?dgcid=rss_sd_all}
}